Appendicular bone density, biochemical markers of bone turnover and lifestyle factors in female teachers of Southern Italy

European Journal of Epidemiology

Volumn 13, Issue 8, 1997, Pages 909-917

  Mariconda, Massimo ^a,c   Pavia, Maria ^a   Colonna, Alfredo ^a,b   Angelillo, Italo F ^a   Marsico, Oscar ^a   Sanzo, Francesco ^a   Mancuso, Carlo ^a   Milano, Carlo ^a  

^a UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Policlinico Mater Domini   (Italy)

Author keywords

Bone mineral density; Menopause; Osteocalcin; Osteoporosis; Pyridinoline; Risk factors

Indexed keywords

BIOCHEMICAL MARKER; OSTEOCALCIN; PYRIDINOLINE;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE MINERAL; BONE TURNOVER; FEMALE; HUMAN; ITALY; LIFESTYLE; MAJOR CLINICAL STUDY; MENOPAUSE; MULTIVARIATE ANALYSIS; OSTEOPOROSIS; PREGNANCY; RISK FACTOR; URINARY EXCRETION;

ADULT; AGE FACTORS; ALCOHOL DRINKING; AMINO ACIDS; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; DIET; FEMALE; HUMANS; ITALY; LIFE STYLE; LINEAR MODELS; MENOPAUSE; MIDDLE AGED; MOTOR ACTIVITY; MULTIVARIATE ANALYSIS; OSTEOCALCIN; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; PARITY; REPRODUCTIVE HISTORY; RISK FACTORS; SMOKING; TEACHING; TIME FACTORS;

EID: 0031444614     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007424507919     Document Type: Article

References (46)

1. Hui SL, Slemenda CW, Johnston CC. Baseline measurement of bone mass predicts fracture in white women. Ann Intern Med 1989; 111: 355-361.
2. Cummings SR, Black DM, Nevitt MC, Browner WS, Cauley JA, Genant HK, Mascioli SR, Scott JC, Seeley DG, Steiger P, Vogt TM. Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group. JAMA 1990; 263: 665-668.
3. Browner WS, Seeley GS, Vogt TM, Cummings SR. Non-trauma mortality in elderly women with low bone mineral density. Study of Osteoporotic Fracture Research Group. Lancet 1991; 338: 355-358.
4. Melton III LJ, Eddy DM, Johnston CC Jr. Screening for osteoporosis. Ann Intern Med 1990; 112: 516-528.
5. Law MR, Wald NJ, Meade TW. Strategies for prevention of osteoporosis and hip fractures. Br Med J 1991; 303: 453-459.
6. Honkanen R, Alhava EM, Saarikoski S, Tuppurainen M. Osteoporosis risk factors in perimenopausal women. Calcif Tissue Int Suppl 1991; 49: 74-75.
7. Dequeker J, Ranstam J, Valsson J, Sigurgevisson B, Allander E. The Mediterranean osteoporosis (MEDOS) study questionnaire. Clin Rheumatol 1991; 10: 54-72.
8. O'Neill TW, Cooper C, Cannata JB, Diaz Lopez JB, Hoszowski K, Johnell O, Lorenc RS, Nilsson B, Raspe H, Stewart O, Silman AJ. Reproducibility of a questionnaire on risk factors for osteoporosis in a multicentre prevalence survey: The European Vertebral Osteoporosis Study. Int J Epidemiol 1994; 23: 559-565.
9. Johnston CC, Melton III LJ, Lindsay R, Eddy DM. Clinical indications for bone mass measurements. A report from the Scientific Advisory Board of the National Osteoporosis Foundation. J Bone Miner Res Suppl 1989; 4: 1-28.
10. Spector TD, Edwards AC, Thompson PW. Use of a risk factor and dietary calcium questionnaire in predicting bone density and subsequent bone loss at the menopause. Ann Rheum Dis 1992; 51: 1252-1253.
11. Kröger H, Tuppurainen M, Honkanen R, Alhava E, Saarikoski S. Bone mineral density and risk factors for osteoporosis: A population-based study of 1600 perimenopausal women. Calcif Tissue Int 1994; 55: 1-7.
12. Christiansen C, Riis BJ, Rødbro P. Prediction of rapid bone loss in postmenopausal women. Lancet 1987; 1: 1105-1108.
13. Uebelhart D, Schlemmer A, Johansen JS, Gineyts E, Christiansen C, Delmas PD. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links. J Clin Endocrinol Metab 1991; 72: 367-373.
14. Brown JP, Delmas PD, Malaval L, Edouard C, Chapuy MC, Meunier PJ. Serum bone Gla-protein: A specific marker for bone formation in postmenopausal osteoporosis. Lancet 1984; 1: 1091-1093.
15. Seyedin SM, Kung VT, Daniloff YN, Hesley RP, Gomez B, Nielsen LA, Rosen HN, Zuk RF. Immunoassay for urinary pyridinoline: The new marker of bone resorption. J Bone Miner Res 1993; 8: 635-641.
16. Schlemmer A, Hassager C, Jensen SB, Christiansen C. Marked diurnal variation in urinary excretion of pyridinium cross-links in premenopausal women. J Clin Endocrinol Metab 1992; 74: 476-480.
17. Stata Corporation. Stata reference manual: 3.1 (6th ed). College Station, 1993.
18. Pujia A, Gnasso A, Mancuso G, Spagnuolo M, Cosco C, Cortese C, Colonna A, Mattioli PL. Asymptomatic peripheral vascular disease. Prevalence and risk factors in a free-living population of southern Italy. Minerva Cardioangiol 1993; 41: 133-138.
19. Fase A del progetto finalizzato del CNR 'Medicina Preventiva-Aterosclerosi-RF 2'. I fattori di rischio dell'aterosclerosi in Italia. G Ital Cardiol Suppl 1980; 10: 51-57.
20. Riis BJ. Biochemical markers of bone turnover in diagnosis and assessment of therapy. Am J Med Suppl 1991; 91: 64-68.
21. Bettica P, Moro L, Robins SP, Taylor AK, Talbot J, Singer FR, Baylink DJ. Bone-resorption markers galactosyl hydroxylysine, pyridinium crosslinks, and hydroxyproline compared. Clin Chem 1992; 38: 2313-2318.
22. Delmas PD, Gineyts E, Bertholin A, Garnero P, Marchand F. Immunoassay of pyridinoline crosslink excretion in normal adults and in Paget's disease. J Bone Miner Res 1993; 8: 643-648.
23. Seibel MJ, Cosman F, Shen V, Gordon S, Dempster DW, Ratcliffe A, Lindsay R. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis. J Bone Miner Res 1993; 8: 881-889.
24. Fledelius C, Riis BJ, Overgaard K, Christiansen C. The diagnostic validity of urinary free pyridinolines to identify women at risk of osteoporosis. Calcif Tissue Int 1994; 54: 381-384.
25. Delmas PD, Stenner D, Wahner HV, Mann KG, Riggs BL. Increase in serum bone gamma-carboxiglutamic acid protein with aging in women. Implications for the mechanism of age-related bone loss. J Clin Invest 1983; 71: 1316-1321.
26. Ohta H, Ikeda T, Masuzawa T, Makita K, Suda Y, Nozawa S. Differences in axial bone mineral density, serum levels of sex steroids, and bone metabolism between postmenopausal and age- and body size-matched premenopausal subjects. Bone 1993; 14: 111-116.
27. Epstein S, McClintock R, Bryce G, Poser J, Johnston CC, Hui S. Differences in serum bone Gla protein with age and sex. Lancet 1984; 1: 307-310.
28. Tarallo P, Henny J, Fournier B, Siest G. Plasma osteocalcin: Biological variations and reference limits. Scand J Clin Lab Invest 1990; 50: 649-655.
29. Del Pino J, Martin-Gomez E, Martin-Rodriguez M, Lopez-Sosa C, Cordero M, Lanchares JL, Garcia-Talavera JR. Influence of sex, age, and menopause in serum osteocalcin (BGP) levels. Klin Wochenschr 1991; 69: 1135-1138.
30. Yasumura S, Aloia JF, Gundberg CM, Yeh J, Vaswani AN, Yuen K, Lomonte AF, Ellis KJ, Cohn SH. Serum osteocalcin and total body calcium and normal pre-and post-menopausal women and postmenopausal osteoporotic patients. J Clin Endocrinol Metab 1987; 64: 681-685.
31. Sherman SS, Tobin JD, Hollis BW, Gundberg CM, Roy TA, Plato CC. Biochemical parameters associated with low bone density in healthy men and women. J Bone Miner Res 1992; 7: 1123-1130.
32. Delmas PD. Biochemical markers of bone turnover: Methodology and clinical use in osteoporosis. Am J Med Suppl 1991; 91: 59-63.
33. Geusens P, Dequeker J, Verstraeten A, Nijs J. Age-, sex- and menopause relating changes of vertebral and peripheral bone: Population study using dual and single photon absorptiometry and radiogrammetry. J Nuc Med 1986; 27: 1540-1549.
34. Nilas L, Christiansen C. Bone mass and its relationship to age and menopause. J Clin Endocrinol Metab 1987; 65: 697-702.
35. Allaway SL, Robinson D, Bailey AR, Hale AC. Bone density, biochemistry and life-style. Methods Inf Med 1993; 2: 233-236.
36. Ryan PJ, Blake GM, Fogelman I. Postmenopausal screening for osteopenia. Br J Rheumatol 1992; 31: 823-828.
37. Rapado A, De La Piedra C, Torres R. BGP (osteocalcin bone-Gla-protein) in involutional osteoporosis. Clin Rheumatol Suppl 1989; 8: 30-34.
38. McLaren AM, Hordon LD, Bird HA, Robins SP. Urinary excretion of pyridinium crosslinks of collagen in patients with osteoporosis and the effects of bone fracture. Ann Rheum Dis 1992; 51: 648-651.
39. Robins SP, Woitge H, Hesley R, Ju J, Seyedin S, Seibel MJ. Direct enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption and estrogen efficacy in postmenopausal osteoporosis. J Bone Miner Res 1994; 9: 1643-1649.
40. Soroko S, Holbrook TL, Edelstein S, Barrett-Connor E. Lifetime milk consumption and bone mineral density in older women. Am J Public Health 1994; 84: 1319-1322.
41. Perez Cano R, Galan Galan F, Dilsen G. Risk factors for hip fracture in Spanish and Turkish women. Bone Suppl 1993; 14: 69-72.
42. Cummings SR. Epidemiologic studies of osteoporotic fractures: Methodologic issues. Calcif Tissue Int Suppl 1991; 49: 15-20.
43. Pocock NA, Eisman JA, Kelly PJ, Sambrook PN, Yeates MG. Effects of tobacco use on axial and appendicular bone mineral density. Bone 1989; 10: 329-331.
44. Hopper JL, Seeman E. The bone density of female twins discordant for tobacco use. N Engl J Med 1994; 330: 387-392.
45. Diamond T, Stiel D, Lunzer M, Wilkinson M, Posen S. Ethanol reduces bone formation and may cause osteoporosis. Am J Med 1989; 86: 282-288.
46. Laitinen K, Välimäki M. Alcohol and bone. Calcif Tissue Int Suppl 1991; 49: 70-73.